These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

593 related items for PubMed ID: 15735310

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
    Hourfar MK, Jork C, Schottstedt V, Weber-Schehl M, Brixner V, Busch MP, Geusendam G, Gubbe K, Mahnhardt C, Mayr-Wohlfart U, Pichl L, Roth WK, Schmidt M, Seifried E, Wright DJ, German Red Cross NAT Study Group.
    Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
    [Abstract] [Full Text] [Related]

  • 4. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.
    Alvarez do Barrio M, González Díez R, Hernández Sánchez JM, Oyonarte Gómez S.
    Euro Surveill; 2005 Feb; 10(2):20-2. PubMed ID: 15735311
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.
    Niederhauser C, Schneider P, Fopp M, Ruefer A, Lévy G.
    Euro Surveill; 2005 Feb; 10(2):14-6. PubMed ID: 15735314
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
    Velati C, Romanò L, Fomiatti L, Baruffi L, Zanetti AR, SIMTI Research Group.
    Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT).
    Pillonel J, Laperche S, Etablissement Français du sang.
    Euro Surveill; 2005 Feb; 10(2):5-8. PubMed ID: 15735313
    [Abstract] [Full Text] [Related]

  • 15. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
    Gonzalez M, Règine V, Piccinini V, Vulcano F, Giampaolo A, Hassan HJ.
    Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
    Weusten JJ, van Drimmelen HA, Lelie PN.
    Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.